Hill's Pet Nutrition vs PetSmart
Side-by-side comparison of AI visibility scores, market position, and capabilities
Colgate-Palmolive subsidiary (NYSE: CL); $4.48B revenue 2024 (+4.4% YoY); #1 vet-recommended therapeutic pet food; Science Diet and Prescription Diet lines sold in 100+ countries
About
Hill's Pet Nutrition is a premium pet food company founded in 1948 by veterinarian Mark Morris Sr., who developed a therapeutic kidney diet for a guide dog — an origin story that established the company's foundational identity as a veterinarian-recommended, science-based nutrition brand. Acquired by Colgate-Palmolive in 1976, Hill's has operated as a wholly owned subsidiary ever since, with its R&D, manufacturing, and go-to-market strategy aligned tightly with the veterinary community as both a clinical partner and primary distribution channel.\n\nHill's product portfolio is organized around two flagship lines: Science Diet, a life-stage and lifestyle nutrition range for healthy pets sold through veterinarians and pet specialty retailers; and Prescription Diet, a therapeutic nutrition line for pets with specific health conditions including kidney disease, urinary issues, obesity, diabetes, and food sensitivities that requires veterinary recommendation. The Prescription Diet line is Hill's most defensible product — its clinical validation, veterinary relationships, and regulatory positioning create high barriers to entry that commodity pet food brands cannot easily overcome.\n\nHill's Pet Nutrition is the veterinarian-recommended #1 pet food brand in the US and a major revenue contributor to Colgate-Palmolive's consumer products portfolio. As pet humanization drives premiumization in the $140B+ global pet care market, Hill's Prescription Diet line benefits from both the growing willingness to spend on pet health and the shift toward preventive and therapeutic nutrition supported by veterinary guidance. The brand's clinical heritage, vet channel dominance, and Colgate-Palmolive's global distribution infrastructure give it a durable competitive position in premium and prescription pet nutrition.
Phoenix BC Partners-owned largest North American specialty pet retailer at $10B FY2023 revenue with 1,500+ stores, Banfield vet clinics, and Chewy equity stake competing with Petco and Chewy for pet care market share.
About
PetSmart is a Phoenix, Arizona-based specialty pet retail chain — privately held since BC Partners' $8.7 billion leveraged buyout in 2015 — operating 1,500+ stores across the United States, Canada, and Puerto Rico as the largest specialty pet retailer in North America, generating approximately $10 billion in revenue in fiscal year 2023 (with Q3 2024 sales of $1.50 billion, +8% year-over-year), serving pet owners with an integrated retail, services, and healthcare ecosystem that includes pet food and supplies, grooming salons, PetsHotel boarding and day camp, Banfield Pet Hospital veterinary clinics (an in-store Mars Inc. franchise), dog training classes, and adoption events partnering with local rescue organizations and shelters. PetSmart holds a significant equity stake in Chewy, Inc. (NYSE: CHWY), having acquired Chewy in 2017 for $3.35 billion before Chewy's 2019 IPO.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.